The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?

Jun 4, 2019

The Lymphoma Hub is pleased to present a series of two interviews with Bianca Santomasso, Memorial Sloan Kettering Cancer Center,on the topic of neurotoxicity in CAR T therapy. Bianca Santomasso talks the Lymphoma Hub through the causes, management, and patients at risk of neurotoxicity during the ASCO 2019 annual meeting in Chicago, US.

Neurotoxicity from CAR T-cell therapy: how can it be managed and who is at risk?